ALZHEIMER'S DRUG DISCOVERY FOUNDATION
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$299,394,693
Receivables (Non-Related)
57%
Investments
24%
Cash & Equivalents
18%
Other Assets
<1%
Prepaid Expenses
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$82,417,926
Grants Payable
92%
Payables & Accruals
4%
Other Liabilities
3%
Deferred Revenue
2%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$40,215,595
$54,917,763
+37%
Receivables (Non-Related)
$188,735,033
$170,715,532
-10%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$403,557
$706,750
+75%
Investments
$92,342,872
$70,622,086
-24%
Property, Plant, & Equipment (net)
$157,807
$134,734
-15%
Other Assets
$2,318,664
$2,297,828
-1%
Total Assets
$324,173,528
$299,394,693
-8%
Liabilities
2023
2024
Change
Payables & Accruals
$2,790,497
$3,274,049
+17%
Grants Payable
$58,002,921
$75,579,333
+30%
Deferred Revenue
$1,034,282
$1,437,114
+39%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$2,355,247
$2,127,430
-10%
Total Liabilities
$64,182,947
$82,417,926
+28%
Net assets
2023
2024
Change
Restricted Net Assets
$185,412,696
$152,005,276
-18%
Unrestricted Net Assets
$74,577,885
$64,971,491
-13%
Net assets
2023
2024
Change
Net assets
+$259,990,581
+$216,976,767
-17%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)